Key Highlights
•
A new quality control pathway in a fungus shows that when cells are stressed, they can segregate and isolate damaged parts of the nucleolus (a key structure inside the cell’s nucleus) during cell division. This reveals a clever cellular strategy to ensure that newly formed cells inherit only healthy, rejuvenated components, which is crucial for maintaining function in complex, multi-nucleated organisms.
Source →
•
Researchers have identified a mechanism that resolves a paradox in cancer biology: how a tumor-suppressing protein (PP2A) can both promote and block the degradation of a powerful cancer-driving protein called c-Myc. They found that a specific form of PP2A (the B55α complex) switches c-Myc onto a different degradation pathway, which could be a new target for controlling its levels in tumors.
Source →
•
Scientists are working to identify the key biological factors that regulate tauopathies, a group of neurodegenerative diseases that includes Alzheimer’s. Understanding these regulators is a critical step toward developing treatments that could slow or halt the progression of these devastating brain disorders.
Source →
•
A new web server called ProteoCast allows scientists to predict and interpret the effects of genetic missense variants, which are small changes in a protein’s DNA code. This tool helps researchers understand how these variants might impact protein function and disease, accelerating genetic research and personalized medicine.
Source →
•
A review highlights the potential of using insulin-like growth factor 1 (IGF-1), a signaling molecule released by stem cells, as a key treatment for ovarian ageing. This approach aims to rejuvenate ovarian function, which could have significant implications for fertility and hormonal health.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
